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Abstract
The generation of induced pluripotent stem cells from adult somatic cells by ectopic expression of key transcription factors
holds significant medical promise. However, current techniques for inducing pluripotency rely on viral infection and are
therefore not, at present, viable within a clinical setting. Thus, there is now a need to better understand the molecular basis
of stem cell pluripotency and lineage specification in order to investigate alternative methods to induce pluripotency for
clinical application. However, the complexity of the underlying molecular circuitry makes this a conceptually difficult task. In
order to address these issues, we considered a computational model of transcriptional control of cell fate specification. The
model comprises two mutually interacting sub-circuits: a central pluripotency circuit consisting of interactions between
stem-cell specific transcription factors OCT4, SOX2 and NANOG coupled to a differentiation circuit consisting of interactions
between lineage-specifying master genes. The molecular switches which arise from feedback loops within these circuits
give rise to a well-defined sequence of successive gene restrictions corresponding to a controlled differentiation cascade in
response to environmental stimuli. Furthermore, we found that this differentiation cascade is strongly unidirectional: once
silenced, core transcription factors cannot easily be reactivated. In the context of induced pluripotency, this indicates that
differentiated cells are robustly resistant to reprogramming to a more primitive state. However, our model suggests that
under certain circumstances, amplification of low-level fluctuations in transcriptional status (transcriptional ‘‘noise’’) may be
sufficient to trigger reactivation of the core pluripotency switch and reprogramming to a pluripotent state. This
interpretation offers an explanation of a number of experimental observations concerning the molecular mechanisms of
cellular reprogramming by defined factors and suggests a role for stochasticity in reprogramming of somatic cells to
pluripotency.
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Introduction
Stem cells are present during all phases of development, from
the embryo to the adult, and are characterized by their ability to
self-renew indefinitely and differentiate along a variety of distinct
lineages. Embryonic stem (ES) cells, which are derived from the
inner cell mass of the developing mammalian blastocyst, are
pluripotent: they have the ability to generate all embryonic tissues.
In contrast, adult stem cells, which reside in small numbers in
almost all adult tissues, are generally multipotent: their regener-
ative potential is tissue or germ-layer specific [1–3]. Nevertheless,
since adult stem cells have the capacity to initiate specific de novo
tissue regeneration subsequent to disease or trauma and may be
derived by biopsy with reduced ethical controversy, they are of
considerable current clinical and biological research interest.
The traditional conceptual model of cellular differentiation is
discrete and hierarchical in nature [4]. In this view, cells can be
one of a number of qualitatively different types (stem, progenitor or
terminal cell for instance) and differentiation proceeds through a
well-defined hierarchy of increasingly committed progenitor cells
which act as transit populations between the most pluripotent stem
cells and terminally differentiated cells, and serve to facilitate rapid
clonal expansion. This process was traditionally thought to
progress through a series of irreversible gene restrictions which
limited dedifferentiation to more primitive states. However, recent
experimental evidence suggests that under certain circumstances
‘‘terminally’’ differentiated cells may retain the capacity to
dedifferentiate to more primitive states and possibly trans-
differentiate to alternative terminal states [3,5–8], although the
molecular mechanisms by which this reprogramming occurs
remain contentious [9].
This flexibility in the differentiation hierarchy is commonly
known as lineage plasticity [3] and is perhaps most dramatically
demonstrated by molecular reprogramming of adult somatic cells
into so-called induced pluripotent stem (iPS) cells [10], which
express the genetic and phenotypic characteristics of pluripotent
ES cells. Since iPS cells potentially provide a patient-specific
source of pluripotent stem cells they possess significant clinical
potential [11]. Furthermore, since they are derived from adult
somatic cells which are easily harvested through biopsy, the
generation and clinical use of iPS cells is not associated with the
same ethical controversies as human ES cells, although they are
associated with significant alternative ethical issues [12]. However,
current techniques to generate iPS cells rely on viral transfection of
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key transcription factors–a process which currently carries the
inherent risk of insertional genetic mutations–and thus are unsuitable
for use in a clinical setting. The search for alternative non-viral
methods to generate iPS cells has focused research attention on the
molecular basis of pluripotency and lineage plasticity.
Although pluripotency is controlled by multiple factors [13], in
recent years the homeodomain transcription factors OCT4 and
NANOG and the HMG-box transcription factor SOX2 have
emerged as playing central roles in the maintenance of ES cell
identity both in mice and humans [14–20]. For example, Boyer
and co-workers used chromatin immunoprecipitation and ge-
nome-scale DNA microarrays to explore the core transcriptional
circuitry in human ES cells [15], while Loh and co-workers used
similar methods to identify OCT4, and NANOG targets in mouse
ES cells [18]. Taken together, three key findings emerge from
these studies: (1) the architecture of the core OCT4/SOX2/NANOG
pluripotency circuit is essentially conserved between mice and
humans [17]. (2) These three factors interact with each other in a
coordinated manner to form a tightly regulated pluripotency
circuit. In particular, the OCT4 and SOX2 proteins form a
heterodimer which positively regulates the expression of all three
of these core transcription factors [18] as well as other targets
[21,22]. Similarly NANOG also positively regulates expression of all
three pluripotency factors [18]. Since the binding loci of these
genes are often almost identical [13] and multi-protein complexes
containing OCT4 and NANOG may be produced by iterative
immunoprecipitation in ES cells [23], evidence suggests that these
three factors most-likely regulate gene expression in a cooperative
manner, as part of multi-protein complexes [13]. (3) OCT4, SOX2
and NANOG co-occupy a large set of developmentally significant
target genes. In particular, they repress expression of genes
associated with cellular differentiation and lineage commitment
while activating expression of genes associated with self-renewal
and pluripotency, including key transcription factors and members
of the TGF-b and Wnt signaling pathways [15,18]. As with their
regulation of each other, it is likely that they also often regulate
these downstream target genes in a coordinated manner [17].
Thus, cooperative interactions between OCT4, SOX2 and NANOG
are central to maintenance of the ES cell identity: appropriate
expression of these 3 factors holds the cell in a pluripotent self-
renewing state by activating ES cell-specific pluripotency genes
and suppressing differentiation genes; while loss of expression
results in up-regulation of differentiation genes, and loss of the
pluripotent stem cell identity.
Commensurate with their roles in maintenance of the ES cell
state, OCT4 and SOX2 also appear to play a central role in
inducing pluripotency in somatic cells [24]. In a series of break-
through papers Takahashi, Yamanaka and co-workers found that
retroviral infection with just four factors–OCT4, SOX2, KLF4 and
c-MYC–was sufficient to transform both adult mouse and adult
human fibroblastic cells to a pluripotent ES cell-like state [10,25].
In particular, they found that subsequent to transfection, drug
selection for expression of the OCT4 target Fbx15 [26] isolated a
sub-population of cells which possessed many ES cell character-
istics including the same gross morphology, the ability to form
teratomas subsequent to subcutaneous injection in nude mice and
the ability to differentiate along all 3 germ layers in vitro. However,
they also found that these cells differed from ES cells in a number
of crucial respects. In particular, they were unable to generate live
chimeras and they differed from ES cells both in genetic and
epigenetic profiles, indicating that these ‘‘first-generation’’ Fbx15-
iPS cells are similar, but not identical to, ES cells.
Since these initial reports, the induction process has been
refined by a number of groups [27–38]. In particular, iPS cells
have been generated from alternative cell types including adult
hepatocytes, gastric epithelial cells [31], and mesenchymal cells
[30]; iPS cells have been generated without transfection with the
proto-oncogene c-MYC [34,36,38]; the drug-selection process–
which requires insertion of a drug-resistance gene into endogenous
loci, and thus carries the risk of insertional mutations–has been
replaced with selection on morphological criteria [33]; alternative
combinations of key transcription factors which are sufficient to
induce pluripotency have been identified [38]; and the efficiency
of the reprogramming process has been improved with the use of
small molecules such as DNA and histone methyltransferase
inhibitors [28,29] and histone deacetylase inhibitors [27].
Crucially, selection for OCT4 or NANOG expression rather than
Fbx15 has been found to yield a more completely reprogrammed
state [32,33,35,37]. The resulting iPS cells are characteristically
ES-like in morphology, proliferative properties, global genetic and
epigenetic status [32], and in their response to key factors such as
retinoic acid and leukemia inhibitory factor [35]. Additionally not
only do they have the capacity to form teratomas in vivo [35,37],
they also support generation of viable live chimeras [35,37] and
late gestation ‘‘all iPS cell’’ embryos through tetraploid comple-
mentation [37]. These results currently suggest that OCT4- and
NANOG-iPS cells are functionally indistinguishable from ES cells.
Taken together these reports also highlight a number of key
observations which any explanation of the reprogramming process
should address [17]. (1) OCT4 and SOX2 appear to be essential to
the reprogramming process, but additional factors such as c-MYC,
KLF4, LIN28 appear to only to improve efficiency [24,34,36,38].
Furthermore, NANOG, although a core determinant of the ES cell
identity, also appears to be dispensable [10,24,25,38]. (2) Viral
gene expression is needed to induce pluripotency, however
maintenance of the undifferentiated state is not reliant on
continued transgene expression, but rather is maintained by
endogenous gene expression [32,33,35,37]. (3) Epigenetic repro-
gramming is important in establishing and maintaining the
induced pluripotent state [24,27,29].
In this paper we shall use a computational model of stem cell
differentiation to explore the molecular basis of cell fate
specification and reprogramming by defined factors.
Methods
The molecular mechanisms which underpin cell fate specification
are inherently complex and difficult to interpret using experiment
and intuition alone. Consequently, many authors have considered
computational models of various aspects of cellular differentiation
(see [39–51] for instance). For example, within a theoretical context
it has long been suggested that distinct cell types may correspond to
attractors of (generally high dimensional) genetic regulatory networks
[46,52]; an idea which has had some recent experimental validation
in mammalian cells [53,54]. Since many cell types naturally coexist
in the body, the notion of a cell type as an attractor implies that the
underlying dynamical regulatory system possess co-existing attrac-
tors. Consequently, differentiation has been extensively interpreted
in terms of switching between co-existing attractors [55,56] and
regulatory architectures which give rise to multistability have been
discussed at length (see [55] and [57,58] and the references therein).
Experimental evidence for switching between multiple discrete states
during mammalian cell differentiation has also recently been
provided [59,60].
In order to better understand stem cell differentiation and
reprogramming we constructed a computational model of
transcriptional control of stem cell differentiation which uses these
ideas and builds upon this literature. As an exemplar system we
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considered differentiation along the principle stromal lineages,
although the regulatory architecture we shall describe occurs in a
similar form in other contexts. Since mesenchymal cells have been
reprogrammed to a pluripotent state [30] this represents a relevant
example.
In addition to the core OCT4/SOX2/NANOG pluripotency circuit
discussed in the introduction we also constructed an extended
regulatory network for differentiation along the osteogenic (bone),
chondrogenic (cartilage) and adipogenic (fat) lineages, based upon
data obtained from an extensive literature search. The network we
obtained consists of direct and indirect interactions between RUNX2,
SOX9 and PPAR-c, the core lineage-specifying master genes
(LSMGs) for osteogenesis, chondrogenesis, and adipogenesis respec-
tively. The architecture of this extended network is given in Fig. 1a.
In order to identify dominant interactions between the core LSMGs
we considered a simple coarse-graining which emerges naturally
from this extended network (see Fig. 1b). In particular, each of the
core LSMGs auto-activates its own production while cross-
repressing expression of the other two, either directly or through
molecular intermediaries.
So, for example, BMP2 up-regulates expression of RUNX2 while
simultaneously down-regulating PPAR-c through activation of the
intermediary transcription factor TAZ [61,62]. Additionally, RUNX2
expression increases sensitivity to exogenous BMP2, for example via
regulation of BMP receptors or SMAD signaling [63]. Thus RUNX2
auto-activates its own expression via a positive feedback loop with
BMP2 and TAZ. Conversely, PPAR-c while a potent activator of
adipogenesis also strongly inhibits osteogenesis [64,65] by both direct
suppression of RUNX2 expression and by altering the potential of
RUNX2 to activate downstream osteogenic products [66,67]. In
contrast, PPAR-c and the CCAAT/enhancer binding protein C/
EBP-a positively regulate each others expression [68]; thus PPAR-c,
like RUNX2, also indirectly positively regulates its own production,
this time through a positive feedback loop with C/EBP-a.
Although such a coarse-graining naturally excludes effects such
as time-delays produced by indirect feedback loops, it allows us to
study interactions between core transcription factors in a
biologically and mathematically transparent manner. Full details
of the extended regulatory network for differentiation along these
stromal lineages, and its coarse-graining may be found in the
supplementary materials (Text S1). We note here that the mutual
cross-inhibition which emerges from this coarse-graining is also
seen in other examples of cell fate specification including
haematopoiesis [69] and specification of neuronal subtypes [70].
Additionally, auto-activation of lineage-determining genes is also
common (for example, in the context of haematopoiesis it has been
found that the myeloid determinant PU.1 and the erythroid
determinant GATA1 are both directly auto-stimulatory [71]).
Thus, the coarse-grained logic we consider (auto-activation and
mutual cross-repression) is not specific to differentiation along the
stromal lineages, but rather may represent a widespread form of
transcriptional regulation of cell fate specification.
Molecular interactions between the core pluripotency factors
(OCT4, SOX2 and NANOG) and the stromal lineage-specifying
master genes (RUNX2, SOX9 and PPAR-c) remain to be fully
characterized. Therefore in order to connect the lineage-specifying
circuit to the core pluripotency circuit, we reasoned that since
RUNX2, SOX9 and PPAR-c are master-genes associated with
differentiation, they are suppressed by OCT4, SOX2 and NANOG,
most likely through intermediate products [15,18] and similarly
that RUNX2, SOX9 and PPAR-c all suppress OCT4, SOX2 and
NANOG, most likely through downstream secreted growth factors.
The resulting core transcriptional circuitry for differentiation from
pluripotent ES cell along the principle stromal lineages is given in
Fig. 2.
In order to study the dynamic behavior of this integrated
network, we developed a computational model which accounts for
the biological processes of interest. The model consists of a set of
six coupled differential equations. For simplicity we present the
model using an indexed notation. Hence, [Pi] gives the nuclear
concentration of the product of the ith pluripotency gene (PG)
where P1 =OCT4, P2 = SOX2 and P3 =NANOG. Similarly, [Li]
gives the nuclear concentration of the ith lineage-specifying factor,
where L1 =RUNX2, L2 = SOX9 and L3 = PPAR-c. In order to
model the effect of the extracellular environment on cell fate
specification, we also accounted for the effects of various
exogenous stimuli on this core circuit. Hence, si represents a
combination of growth factors which stimulates differentiation
along the ith lineage. So, for example, murine ES cells are
stimulated to osteogenesis through up-regulation of RUNX2 by
Figure 1. The mesenchymal transcriptional web (a) and its coarse-graining (b). Arrows indicate up-regulation, bars indicate down-
regulation.
doi:10.1371/journal.pone.0003086.g001
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retinoic acid (RA)+BMP4; to chondrogenesis through up-regula-
tion of SOX9 by RA+TGF-b; and to adipogenesis through up-
regulation of PPAR-c RA+Insulin [72]. Thus, we may consider
s1 = [RA+BMP4], s2 = [RA+TGF-b] and s3 = [RA+Insulin]. Note
that although these three stimuli are lineage-specific, they all
contain a common element (RA), thus they all partially stimulate all
three lineages. Furthermore, since RA suppresses OCT4, SOX2
and NANOG expression [73], all three differentiation stimuli also
suppress the core pluripotency circuit.
Based upon the logic above, on the structure of Fig. 2 and
subsequent to biologically realistic simplifying assumptions (see
supplementary Text S1) we obtained the following system of
equations.
d Pi½ 
dt
~
k1i P1½  P2½  1z P3½ ð Þ
1zk0
P
j
sj
 !
1z P1½  P2½  1z P3½ ð ÞzkPL
P
j
Lj
  !{b Pi½  ð1Þ
d Li½ 
dt
~
k2 sizk3
P
j=i
sj
 !
Li½ 2m
1zkLC1 P1½  P2½ zkLC2 P1½  P2½  P3½ z Li½ 2zkLL sizk3
P
j=i
sj
 !P
j=i
Lj
 2
{b Li½ 
ð2Þ
Full details of the derivation of this model and a biological
interpretation of the model parameters can be found in the
supplementary materials (Text S1). A model of the core OCT4/
SOX2/NANOG pluripotency circuit based upon similar assump-
tions has been considered elsewhere [40].
We may summarize the transcriptional logic given in Fig. 2 and
Eqns. (1–2) as follows: the transcription of each core PG is activated
by OCT4-SOX2 and OCT4-SOX2-NANOG multi-protein complexes
[40]. Conversely, the transcription of each LSMG is suppressed by
the OCT4-SOX2 and OCT4-SOX2-NANOGmulti-protein complexes.
Additionally, each LSMG auto-activates its own production, while
cross-repressing that of the other LSMGs and the core PGs.
Furthermore, each LSMG is up-regulated by environmental (specific
and non-specific) differentiation stimuli; while each PG is down-
regulated by environmental differentiation stimuli.
Results
Differentiation: An Irreversible Sequence of Controlled
Gene Restrictions
We have conducted an extensive numerical investigation of
Eqns. (1–2) and a full mathematical analysis of a simplified system
(see below and supplementary materials Text S1). Here we
summarize the key findings of these analyses, and discuss their
biological implications. We shall focus on stable steady-state
(equilibrium) solutions of this computational model. Since
numerical simulations suggest that this model does not exhibit
limit cycles or chaotic trajectories such equilibria represent the
primary behavior of the system after any brief transients.
In accordance with the notion of a cell type as an attractor
[46,52] we associate stable equilibria with fixed cellular pheno-
types. In common with other models of cellular differentiation, the
system given by Eqns. (1–2) allows multiple stable steady-states
Figure 2. The core transcriptional circuitry for stem cell differentiation along the stromal lineages. Arrows indicate up-regulation, bars
indicate down-regulation.
doi:10.1371/journal.pone.0003086.g002
ð2Þ
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(cell types) to coexist in the same environment. This multistability
derives from the positive feedback loops in the transcriptional
circuitry [55] and results in a sequence of genetic ‘‘switches’’ (that
is, binary responses to continuously graded stimulus), which
correspond to a sequence of successive gene restrictions.
In order to consider the molecular basis of differentiation from a
pluripotent state to a terminal state, we began by considering the
response of a cell initially in a pluripotent state to increasing
environmental differentiation stimulus. For simplicity we consider a
pluripotent ES cell in culture in which osteogenesis is initiated by
addition of s1 =RA+BMP4 to the culture media in increasing doses.
Since the equations have the same essential form for each lineage,
our conclusions also hold quantitatively for chondrogenic induction
by RA+TGF-b and adipogenic induction by RA+Insulin.
In the pluripotent state all three PGs are active (in Boolean
terms, they are ON) and all three LSMGs are inactive (in Boolean
terms, they are OFF): numerical simulations suggest that this state is
stable as long as the environmental stimulus (in this case the
concentration of RA+BMP4) is not too high. However, as the
environmental stimulus is increased the PGs are increasingly
suppressed, and their expression level gradually falls. This
continues until a threshold is reached, at which point the PGs
can no longer maintain suppression of the LSMGs any further and
one or more of the LSMGs switch ON.
Numerical simulations suggest that at this point the system can
display a number of different behaviors, depending upon the
parameter regime. However, in all cases, we found that
differentiation proceeds through a sequence of irreversible
switches, corresponding to irreversible gene restrictions. Similar
irreversible switches due to positive feedback loops have been
observed both theoretically and experimentally in other develop-
mental contexts (for an excellent example which combines both
experiments and modeling see [74]). Fig. 3 shows examples of the
various gene restriction sequences which this model exhibits for
Figure 3. Differentiation from pluripotent stem cell to terminal osteoblast occurs either directly or through a hierarchy of
increasingly committed cell types. In all panels blue indicates equilibrium OCT4/SOX2 expression; red indicates equilibrium NANOG expression;
green indicates equilibrium SOX9 expression; dashed purple indicates equilibrium PPAR-c expression; and black indicates equilibrium RUNX2
expression. The vertical grey dotted lines mark the points when a differentiation event occurs. These figures should be read left to right since they
illustrate stimulus increasing with time. (a) Differentiation straight from a pluripotent state to a terminal ostoblastic state (model parameter values:
k0 = 10, k11 = 1, k12 = 0.5, k2 = 1, k3 = 0.9, kPL=2.5, kLC1~0:5, kLC2~1:1, kLL= 1,m=0.875, b= 0.1); (b) Differentiation straight from a pluripotent state to
a terminal ostoblastic state via a primed state (model parameter values: k0 = 5, k11 = 1, k12 = 0.5, k2 = 5, k3 = 0.9, kPL= 0.5, kLC1~0:1, kLC2~0:05, kLL= 1,
m=0.625, b=0.1); (c) Differentiation from a pluripotent state to a terminal osteoblastic state through a hierarchy of increasingly committed tissue-
specific progenitors (model parameter values: k0 = 25, k11 = 1, k12 = 0.5, k2 = 3, k3 = 0.9, kPL=10, kLC1~2, kLC2~2, kLL=1, m= 0.75, b= 0.1); (d)
Differentiation from a pluripotent state to a terminal osteoblastic through a hierarchy of increasingly committed tissue-specific progenitors via a
primed state (model parameter values: k0 = 20, k11 = 1, k12 = 0.5, k2 = 7, k3 = 0.9, kPL= 0.1, kLC1~0:1, kLC2~0:01, kLL= 0.75, m=0.575, b= 0.1). Video
versions of these bifurcation diagrams are given in the supplementary materials (Videos S1, S2, S3, S4). Details of the biological meaning of each of
the model parameters are given in the supplementary materials (Text S1).
doi:10.1371/journal.pone.0003086.g003
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different parameter regimes. We have also included video
animations of these bifurcation diagrams in the supplementary
materials (Videos S1, S2, S3, S4), which present these switching
dynamics in a more intuitive manner.
For some parameter values we found that the cell differentiates
directly from a pluripotent state to a terminal osteoblastic state in
which RUNX2 alone is active (see Fig. 3a); while for other parameter
values we found that differentiation proceeds through a sequence of
intermediary states in which competing LSMGs are co-expressed
before the terminal state is obtained (see Fig. 3c,d). Promiscuous
expression of competing master genes has been discussed previously
and associated with developmental multipotency prior to lineage
commitment [75]. For example, concurrent expression of RUNX2,
SOX9 and PPAR-c has been observed in the early stages of murine ES
cell differentiation along the osteogenic lineage and associated with
osteogenic/chondrogenic/adipogenic multipotency [76]. Similarly,
co-expression of GATA1 and PU.1 has also been observed during
haematopoiesis and similarly associated with multipotency [45]. In
accordance with these observations, we associated the state in which
all three LSMGs are concurrently expressed (but the PGs are OFF)
with a tripotent state, and the state in which all two of the three LSMGs
are concurrently expressed (but the PGs are OFF) with a bipotent state.
In both the tripotent and bipotent states, pluripotency has been lost
but some limited tissue-specific regenerative potential is retained.
For some parameter regimes, we found that the system can also
adopt a state in which the PGs and LSMGs are co-expressed at a
low level. Of all the switches we observed, only the switch from the
pluripotent state to this PG/LSMG co-expressing state, was
reversible: removal of stimulus from a cell in this state results in
immediate transition back to the pluripotent state. Thus, we
interpret the PG/LSMG co-expressing state as corresponding to a
primed state in which the cell is preparing to commit to
differentiation but commitment to a differentiating state has not
yet been made. Such primed states, in which multiple LSMGs are
co-expressed, have been suggested as a characteristic feature of
tissue-specific (haematopoietic) stem cells [50,77,78]; similarly,
evidence that key genes may be primed for activation in ES cells
has also been presented [15,79].
In order to investigate the nature of the switches which were
observed during differentiation, we examined the stability of the
various cell types–pluripotent, tripotent, bipotent and terminal–as
environmental stimulus is varied. Fig. 4. shows the stability of the
various cell types for a biologically representative parameter
regime. Importantly, for low levels of stimulus, all cell types are
concurrently stable. As environmental stimulus is increased, the
cell types lose stability sequentially in order of developmental
potency. Thus, for high levels of stimulus only the terminal state is
stable; while for intermediate levels of stimulus the tripotent,
bipotent and terminal states are concurrently stable; and for low
stimulus all four cell states are concurrently stable.
In order to investigate the nature of the switches which occur
during differentiation more rigorously we also considered behavior
of a related (but highly simplified) model analytically. In this
simplified model the core PGs are inactive and the interactions
between the LSMGs as given in Fig. 1b in response to a generic
differentiation stimulus a are considered. Thus, this model focuses
on the series of secondary bifurcations which occur after the core
pluripotency circuit has been switched OFF. In particular, we
considered the following system of equations:
d Li½ 
dt
~
Li½ 2
1z Li½ 2za
P
j=i
Lj
 2{b Li½  ð3Þ
Full details of our mathematical analysis of this model are provided
in the supplementary materials (Text S1). A similar model of
transcriptional control of differentiation is considered in [41,42].
In supplementary Text S1 we show analytically that this
simplified model supports a monotonic increasing sequence of
bifurcation points, in which cell types lose stability sequentially:
For 0#a,a1 the multipotent state in which all three LSMGs are
simultaneously expressed is stable; for 0#a,a2 (where a2.a1) the
bipotent states in which 2 of the LSMGs are co-expressed are
stable; and for 0#a,a3 (where a3.a2) the terminal states in which
only one LSMG is expressed are all stable. Consequently, this
simplified model exhibits multistability: for 0#a,a1 all three cell
types (multipotent, bipotent and terminal) are simultaneously
stable. However, as stimulus is increased above the threshold a1
the multipotent state becomes unstable, gene expression is
restricted and the cell is forced to adopt a bipotent state. For
0#a,a2 the bipotent and terminal states are simultaneously stable
but the multipotent state is unstable. However as stimulus is
increased above the threshold a2 the bipotent state also becomes
unstable, gene expression is further restricted and the cell is forced
into a terminal state. Since the terminal states are stable for a,a3,
removal of environmental stimulus does not result in dedifferen-
tiation to the bipotent or multipotent states. Similarly, since a2.a1,
once the cell has adopted a bipotent state it cannot dedifferentiate
to a multipotent state. We believe that a similar monotonic
increasing sequence of bifurcation points underpins the irreversible
switching dynamics of the full model and in particular that the full
system does not exhibit hysteresis within a biologically relevant
parameter regime.
The central point to note from this discussion is that the
molecular switches which arise from feedback loops in the core
regulatory circuitry naturally give rise to a well-defined sequence
of successive and irreversible gene restrictions corresponding to a
directed differentiation cascade in response to specific environ-
mental stimuli. However, the analysis we have given so far does
not account for stochastic fluctuations in transcriptional status. In
fact, gene expression is an inherently stochastic process [80], and
transcriptional ‘‘noise’’ can profoundly affect cell fate decisions
[81–86]. In the following section we explore a role for
transcriptional noise in triggering stochastic transitions between
co-existing attractors. In particular, we focus on exploring noise-
driven transitions between the terminal state and the pluripotent
state with the aim of better understanding the molecular basis of
induced pluripotency.
Cellular Reprogramming: A Role for Stochasticity
In order to consider the effect of molecular noise on system
dynamics it is convenient to think of the various cell types we have
identified as local minima of an energy landscape which is
continually being shaped by external stimuli, and the behavior of
the cell as a particle moving through this landscape to minimize its
energy [87–89]. In this view, the local minima corresponding to
the pluripotent, multipotent and bipotent cell types become
increasingly shallow as differentiation stimulus is increased, until at
the critical threshold points they disappear in consecutive order.
Thus, a cell initially at the minimum corresponding to the
pluripotent state is forced to transition through a hierarchy of local
minima as environmental stimulus is increased, until finally it
arrives at the ‘‘terminal’’ minimum corresponding to the fully
differentiated state. If, at this point, environmental stimulus is
gradually removed, then the local minima corresponding to the
primitive cell types reappear sequentially in reverse order.
However, since the switches we have identified are irreversible,
the terminal minimum does not disappear upon removal of
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stimulus and the cell must therefore overcome an energy barrier if
it is to escape the terminal state.
Stochastic fluctuations in transcriptional status (transcriptional
‘‘noise’’) may be thought of, in the first instance, by analogy to the
temperature of the particle in the energy landscape. If the terminal
minimum is deep and/or fluctuations in transcriptional status are
small (for example, if they are suppressed by epigenetic or other
means) then stochastic transitions from the terminal state to
alternative (more primitive) states will be rare [90]. However, if the
terminal minimum is shallow and/or fluctuations in transcriptional
status are large then stochastic transitions from the terminal state to
alternative states will be more common. Thus, the frequency and
type of noise-driven transitions between cell states depends both
upon the structure of the attractor landscape and the form and
amplitude of noise in the system. The notion of noise-driven
transitions between co-existing attractor states has been well
explored theoretically and experimentally in model organisms (see
the recent reviews [84,85] and references therein); and has recently
had some experimental demonstration in mammalian cells [54].
In the previous section we examined the behavior of a cell
initially in a pluripotent state to a gradual increase in
environmental stimulus and found that differentiation occurs
through an irreversible sequence of gene restrictions. In this
section, we examine the behavior of a cell initially in a
differentiated state to removal of differentiation stimulus, and
investigate a role for stochasticity in triggering transitions from a
differentiated state to the pluripotent state.
Fig. 4 illustrates the stability of the various cell types for varying
environmental stimulus and shows that at low levels of
environmental stimulus the differentiated (osteoblastic) cell adopts
a state in which RUNX2 is expressed at a low level (and all other
PGs and LSMGs are OFF); and that upon complete removal of
stimulus RUNX2 expression also tends to zero. Linear stability
analysis shows that in the absence of environmental stimulus this
state (the origin) is stable for all model parameter values as long as
the protein decay-rate b.0. Furthermore, analysis of Eqns. (1–2)
shows that in the absence of environmental stimulus, only the
origin and the pluripotent state are stable.
In order to investigate the effect of transcriptional noise on
system dynamics we included a time-dependent stochastic term in
Eqns. (1–2). In vector notation we denote the state of the system by
x= [P1, P2, P3, L1, L2, L3] and the right-hand-side of Eqns. (1–2) by
F(x). Thus, we considered the following set of stochastic differential
equations:
dx~F xð Þdtzs dW ð4Þ
Here s is a diagonal matrix of constants representing the
amplitude of noise, where sii gives the amplitude of the noise in
expression of the ith gene, and W denotes a Weiner process
(Brownian motion).
Fig. 5 shows some representative simulations of Eqns. 4
illustrating the behavior of a terminally differentiated osteoblast
upon complete removal of differentiation stimuli (that is, starting
from the origin, in the absence of environmental stimulus). In each
panel 50 separate simulations are shown–each of which may be
thought of as the behavior of an individual cell within an isogenic
population–in which all genes are subjected to the same level of
noise (sii=s for all i). For low-levels of transcriptional noise
stochastic transitions to the pluripotent state do not occur (Fig. 5a).
However, as the level of noise in the system is increased, stochastic
transitions to the pluripotent state increase in frequency (Fig. 5b–
d). Finally, almost all simulations result in a transition to the
pluripotent state (Fig. 5d).
In order to further explore the role of stochasticity in cellular
reprogramming we investigated how reprogramming efficiency
varies with both the form and amplitude of transcriptional noise.
Fig. 6 shows the results of these investigations. Fig 6a illustrates
reprogramming efficiency (the fraction of simulations which
resulted in a noise-driven transition to the pluripotent state) in
the presence of noise in the expression of the PGs only (blue); and in
the presence of noise in the expression of OCT4 and SOX2 only
(red). This figure shows that only very low-level stochastic
fluctuations in PG levels are needed to efficiently reprogram
terminally differentiated cells to the pluripotent state. The fact that
reprogramming efficiency does not change significantly when
fluctuations in NANOG are suppressed suggests that NANOG is not
required to reactivate the pluripotency switch, and therefore is not
required for reprogramming. Fig. 6b illustrates reprogramming
efficiency in the presence of noise in all 6 genes (blue), and in the
presence of noise in the LSMGs only (green), and NANOG only
(red). This figure shows that noise in the expression of the LSMGs
or NANOG alone is unable to trigger stochastic transitions to the
pluripotent state. However, it also illustrates that amplification of
noise in the expression of all 6 genes is sufficient to trigger
transitions to the pluripotent state, albeit less efficiently than by
targeted amplification of OCT4 and SOX2 noise (compare Figs. 6a–
b). This reduction in efficiency occurs since fluctuations in the PGs
and the LSMGs antagonize each other: fluctuations in OCT4/
SOX2 expression serve to activate the pluripotency switch while
fluctuations in the LSMGs serve to suppress the pluripotency
switch.
Taken together Figs. 5–6 illustrate 2 phenomena. (1) in the
absence of environmental stimulus to differentiate (for example in
the ES cell culture conditions), targeted upregulation of OCT4 and
SOX2 protein levels is necessary and sufficient to reprogram a
differentiated cell to the pluripotent state. (2) In the absence of
environmental stimulus to differentiate, non-specific widespread
amplification of transcriptional noise–in this case, amplification of
noise in the expression of all 6 genes–is also sufficient to trigger
stochastic transitions to the pluripotent state. Thus, these
simulations suggest that elevated levels of OCT4 and SOX2 protein
Figure 4. Cell types lose stability sequentially in order of
developmental potency. The y-axis denotes total equilibrium gene
expression ([P1]+[P2]+[P3]+[L1]+[L2]+[L3]). Bold lines indicate stable
solutions; dotted lines indicate unstable solutions. Note that the cell
types lose stability sequentially in order of developmental potency.
Note also that for low-levels of stimuli all four cell types are
concurrently stable: thus, the sequence of gene restrictions we observe
are irreversible. Model parameter values are as in Fig. 3c.
doi:10.1371/journal.pone.0003086.g004
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levels are required for reprogramming. However, they also suggest
that it is not necessary to target OCT4 and SOX2 specifically, but
rather reprogramming may also be achieved by widespread non-
specific amplification of transcriptional noise.
Discussion
The molecular mechanisms of cell fate specification and
reprogramming are clearly much more complex than accounted
for in our simple mathematical model. Nevertheless, simplified
models, such as the one presented, can be useful in conceptualizing
the behavior of complex systems and can lead to insight not
immediately available by experiment alone. With this caveat in
mind, our results offer an explanation of a number of experimental
observations concerning the molecular basis of differentiation and
reprogramming by defined factors. In particular, the model we
have presented shows that the molecular switches which arise from
feedback loops within core transcriptional circuitry naturally give
rise to a well-defined sequence of successive irreversible gene
restrictions which correspond to a controlled differentiation
cascade in response to environmental stimulus. Thus, in the
absence of molecular fluctuations in transcriptional status,
differentiation is unidirectional and cells are strongly resistant to
reprogramming to a more primitive state. However, we found that
under the right environmental circumstances, both targeted and
non-specific amplification of stochastic fluctuations in transcrip-
tional status was sufficient to trigger cellular reprogramming to a
pluripotent state.
In the context of induced pluripotency, a central conclusion of
this work is that in order to reprogram a terminally differentiated
cell to a more primitive state it is necessary to supply it with sufficient
‘‘energy’’ to overcome the barrier holding it in the differentiated
state. Current reprogramming techniques achieve this by inducing
high levels of OCT4 and SOX2 expression from viral transgenes
which in turn reactivate the endogenous pluripotency switch.
However, our results suggest that since only low-level transient
fluctuations in OCT4 and SOX2 protein levels are required, it is
possible that this may be achieved through alternative, less invasive,
methods. The fact that transient expression of the OCT4 and SOX2
proteins is sufficient to reestablish sustained OCT4, SOX2 and NANOG
gene expression explains the experimental observation that
transient retroviral gene expression is needed to establish to
reprogrammed state, yet pluripotency is maintained by sustained
endogenous gene expression [32,33,35,37]. Similarly, this result also
explains why ectopic expression of OCT4 and SOX2 appear
necessary for the reprogramming process but NANOG appears
dispensable [10,24,25,38].
Previous authors have observed that subsequent to early cellular
differentiation core PGs such as OCT4 undergo a robust multi-step
silencing procedure beginning with transcriptional repression
Figure 5. Non-specific noise can trigger reprogramming to a pluripotent state. In each panel 50 representative simulations are shown in
which the expression levels of the LSMGs are given in red; the expression of NANOG is given in blue; and the expression levels of OCT4 and SOX2 are
given in black. In each panel the same amplitude of noise is applied to all 6 genes (in Eqns. 4 sii= s for all i). (a) s= 0.01; (b) s=0.025; (c) s= 0.1; (d)
s= 0.25. Model parameter values are as in Fig. 3c.
doi:10.1371/journal.pone.0003086.g005
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followed by an increase in histone H3 methylation and local
heterochromatinization [17,91]. This stable form of epigenetic
silencing is important since it prevents harmful ectopic reactivation
of PGs (ectopic activation of OCT4 results in dysplasia in gastric
epithelial tissues [92], for example). However, it also ensures that
the low-level fluctuations in OCT4 and SOX2 protein levels needed
for reprogramming are not easy to induce from endogenous genes.
Thus, stable epigenetic silencing of key PGs such as OCT4 and
SOX2 effectively suppresses spontaneous reprogramming by
heavily silencing molecular fluctuations in the nuclear levels of
these proteins.
Previous authors have hypothesized that additional factors such
as c-MYC and KLF4 facilitate reprogramming by modulating
accessibility of the OCT4 and SOX2 loci [24,25]. For example, c-
MYC occupation is associated with genome-scale alteration of
chromatin structure and histone accessibility [13,93], possibly by
stimulation of DNA replication [94] or by binding to multiple sites
[24]; while KLF4 regulates histone acetylation [24,95]. Recent
reports demonstrating the ability of small molecules such as DNA/
histone methyltransferase inhibitors and histone deacetylase
inhibitors to improve reprogramming efficiency [27–29] appear
to support this view. Our results also support this hypothesis and
suggest that by regulating OCT4 and SOX2 accessibility, additional
reprogramming factors such as these increase sensitivity of the core
pluripotency circuit to OCT4 and SOX2 protein levels thus
increasing the probability of transitions to the pluripotent state.
In addition to confirming a central role for OCT4 and SOX2 in
reprogramming by defined factors, our model also suggests that non-
specific widespread amplification of transcriptional noise may aid
reprogramming of somatic cells to a pluripotent state. Rather than
targeted activation of the core pluripotency circuit by defined factors,
this approach may be thought of as giving a non-specific ‘‘shake’’ to
the system in order to realign it to the pluripotent ground state. Since
a role for transcriptome-wide noise in defining mammalian cell fates
has recently been experimentally demonstrated [54], we surmise that
noise-processing mechanisms such as the proteasome [96] (which is
involved in protein homeostasis and is used to target pre-initiation
complexes and minimize noise in differentiation genes in ES cells
[79]) and the Wnt signaling pathway (which has been implicated in
filtering transcriptional noise [82]) may prove fruitful targets for
future research into improving the efficiency of reprogramming
protocols. Such approaches are currently under experimental
investigation in our laboratory.
We conclude by noting that although iPS cells are not associated
with the same ethical concerns as the derivation of human ES cells,
they are nevertheless associated with their own set of significant
ethical considerations [12]. It is important that these are addressed
concurrently with research in this area.
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